Literature DB >> 16816056

Defibulation to treat female genital cutting: effect on symptoms and sexual function.

Nawal M Nour1, Karin B Michels, Ann E Bryant.   

Abstract

OBJECTIVE: Women who have undergone type III female genital cutting may suffer long-term complications. Defibulation (reconstructive surgery of the infibulated scar) can alleviate some of these complications. We studied the physical and sexual outcomes after defibulation and evaluated both patient and husband satisfaction.
METHODS: The medical records of 40 consecutive women with a history of type III female genital cutting who underwent defibulation between 1995 and 2003 were reviewed. Data collected included demographics, indications for the procedure, closure type, intraoperative and postoperative complications. Telephone surveys were conducted between 6 months and 2 years postprocedure to evaluate the long-term health and sexual satisfaction outcomes.
RESULTS: Of 40 women identified as having undergone defibulation, 95% were Somali, 65% were married, and 73% were between the ages of 19 and 30. Primary indications for defibulation were being pregnant (30%), dysmenorrhea (30%), apareunia (20%), and dyspareunia (15%). Secondary indications were apareunia (20%), difficulty urinating (12.5%), and dyspareunia (10%). Sixty-five percent had a subcuticular repair. Forty-eight percent had an intact clitoris buried beneath the scar. None had intraoperative or postoperative complications. Of the 32 patients reached by telephone, 94% stated they would highly recommend it to others. One hundred percent of patients and their husbands were satisfied with the results, felt their appearance had improved, and were sexually satisfied.
CONCLUSION: Defibulation is recommended for all infibulated women who suffer long-term complications. The complication rates are minimal, with high satisfaction rates among patients and their husbands. LEVEL OF EVIDENCE: II-3.

Entities:  

Mesh:

Year:  2006        PMID: 16816056     DOI: 10.1097/01.AOG.0000224613.72892.77

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  15 in total

1.  Female genital circumcision/mutilation: implications for female urogynaecological health.

Authors:  Katharina Teufel; Daniela Marianne Dörfler
Journal:  Int Urogynecol J       Date:  2013-07-16       Impact factor: 2.894

2.  An unusual cause of apareunia.

Authors:  Ahmed Abdel Karim; Anthony D Clayson; Amanda S Jones
Journal:  BMJ Case Rep       Date:  2009-09-02

3.  Female genital mutilation reversal: a general approach.

Authors:  Mallika Anand; Todd J Stanhope; John A Occhino
Journal:  Int Urogynecol J       Date:  2014-01-22       Impact factor: 2.894

Review 4.  Clitoral reconstruction: challenges and new directions.

Authors:  Michela Villani
Journal:  Int J Impot Res       Date:  2022-04-13       Impact factor: 2.896

Review 5.  Defibulation can recall the trauma of female genital mutilation/cutting: a case report.

Authors:  Gianmarco Taraschi; Emily Manin; Francesco Bianchi De Micheli; Jasmine Abdulcadir
Journal:  J Med Case Rep       Date:  2022-05-24

6.  An Introduction to Global Women's Health.

Authors:  Nawal M Nour
Journal:  Rev Obstet Gynecol       Date:  2008

7.  Female Genital Cutting: Clinical knowledge, Attitudes, and Practices from a Provider survey in the US.

Authors:  Jessica L Lane; Crista E Johnson-Agbakwu; Nicole Warren; Chakra Budhathoki; Eugene C Cole
Journal:  J Immigr Minor Health       Date:  2019-10

8.  Female genital cutting: a persisting practice.

Authors:  Nawal M Nour
Journal:  Rev Obstet Gynecol       Date:  2008

9.  Sculptors of African Women's Bodies: Forces Reshaping the Embodiment of Female Genital Cutting in the West.

Authors:  Crista E Johnson-Agbakwu; Emily Manin
Journal:  Arch Sex Behav       Date:  2020-04-23

10.  Female genital mutilation management in the ambulatory clinic setting: a case study and review of the literature.

Authors:  Spencer Craven; Alex Kavanagh; Rose Khavari
Journal:  J Surg Case Rep       Date:  2016-06-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.